Related Experiment Video
Updated: Jun 7, 2026
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
The frequency of NPM1 mutations in childhood acute myeloid leukemia
Maria Braoudaki1, Chrissa Papathanassiou, Katerina Katsibardi
1University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children's Hospital, Athens, Greece. mbraouda@yahoo.co.uk
Background:
Mutations in the nucleophosmin (NPM1) gene have been solely associated with childhood acute myeloid leukemia (AML). We evaluated the frequency of NPM1 mutations in childhood AML, their relation to clinical and cytogenetic features and the presence of common FLT3 and RAS mutations.
Results:
NPM1 mutations were found in 8% of cases. They involved the typical type 'A' mutation and one novel mutation characterized by two individual base pair substitutions, which resulted in 2 amino acid changes (W290) and (S293) in the NPM protein. FLT3/ITD mutations were observed in 12% of the cases and in one NPM1-mutated case bearing also t(8;21) (q22;q22). No common RAS mutations were identified.
Conclusions:
A relatively consistent NPM1 mutation rate was observed, but with variations in types of mutations. The role of different types of NPM1 mutations, either individually or in the presence of other common gene mutations may be essential for childhood AML prognosis.
Insights
Nucleophosmin (NPM1) gene mutations occur in 8% of childhood acute myeloid leukemia (AML) cases, including a novel mutation type. Understanding these NPM1 mutations and their interactions with other gene mutations is crucial for childhood AML prognosis.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Mutations in the nucleophosmin (NPM1) gene are primarily linked to childhood acute myeloid leukemia (AML).
- Investigating NPM1 mutations is essential for understanding AML pathogenesis.
Purpose of the Study:
- To determine the frequency of NPM1 mutations in childhood AML.
- To analyze the association between NPM1 mutations and clinical/cytogenetic features.
- To assess the co-occurrence of NPM1 mutations with FLT3 and RAS mutations.
Main Methods:
- Screening for NPM1 mutations in childhood AML patient samples.
- Characterization of identified NPM1 mutations, including novel variants.
- Testing for common FLT3/ITD and RAS mutations.
Main Results:
- NPM1 mutations were detected in 8% of childhood AML cases.
- The common type 'A' mutation and a novel mutation (W290/S293) were identified.
- FLT3/ITD mutations occurred in 12% of cases, with one NPM1-mutated case also having t(8;21).
- No common RAS mutations were found.
Conclusions:
- A consistent rate of NPM1 mutations was observed in childhood AML, with diverse mutation types.
- The specific types of NPM1 mutations and their interplay with other genetic mutations may significantly impact prognosis in childhood AML.
Related Concept Videos
01:39Mutations
01:35Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
01:20Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
02:26Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
02:21Cancers Originate from Somatic Mutations in a Single Cell